Integra Lifesciences Holdings (IART) Liabilities from Discontinued Operations (2014 - 2022)
Integra Lifesciences Holdings (IART) posted Liabilities from Discontinued Operations of 2303000.0 for Q2 2022, down 80.4% sequentially from 11751000.0 in Q4 2020.
Integra Lifesciences Holdings (IART) Liabilities from Discontinued Operations (2014 - 2022) Analysis & Trends
Integra Lifesciences Holdings has reported Liabilities from Discontinued Operations for 3 years, with the latest figure at 2303000.0 in Q2 2022.
- Quarterly Liabilities from Discontinued Operations changed N/A year-over-year to 2303000.0 in Q2 2022, while the trailing twelve-month figure through Jun 2022 was 2303000.0 (changed N/A YoY) and the FY2020 annual result came in at 11751000.0, changed N/A from the prior year.
- Liabilities from Discontinued Operations declined to 2303000.0 in Q2 2022 per IART's latest filing, from 11751000.0 in the prior quarter.
- Over five years, Liabilities from Discontinued Operations peaked at 12349000.0 in Q3 2020 and troughed at 2303000.0 in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn |
| 10 | Integra Lifesciences Holdings | 1.29 Bn | 1.02 Bn | 219.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | 2.30 Mn |
| Jun 30, 2022 | 2.30 Mn |
| Dec 31, 2020 | 11.75 Mn |
| Dec 31, 2020 | 11.75 Mn |
| Sep 30, 2020 | 12.35 Mn |
| Sep 30, 2020 | 12.35 Mn |
| Dec 31, 2014 | 13.78 Mn |
| Dec 31, 2014 | 13.78 Mn |